David G. Witte

Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects

Timothy A. Esbenshade, Kathleen M. Krueger, Thomas R. Miller et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 101 citations · Full text

Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties

Timothy A. Esbenshade, Gerard B. Fox, Kathleen M. Krueger et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 99 citations · Full text

Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist

Arthur A. Hancock, Youssef L. Bennani, Eugene N. Bush et al. · European Journal of Pharmacology · 2004 · 96 citations · Full text

Medicinal Chemistry, Allergy, Pharmacological Study +6

H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats

Gin C. Hsieh, Prasant Chandran, Anita K. Salyers et al. · Pharmacology Biochemistry and Behavior · 2009 · 82 citations

Inflammation, Pain Therapy, Anti-nociceptive Effects +14

Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis.

Kevin Murray, Lorie Luyrink, Alexei A. Grom et al. · PubMed · 1996 · 82 citations